Canaccord Genuity analyst William Plovanic maintained a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of $269.00. William Plovanic has given his Buy rating due to a ...
5 The 1980s were a particularly strong time for diabetes awareness and research, in part due to insulin made of recombinant DNA and the availability of at-home products that allowed patients to test ...
Read more about our advertising policy. The speed test sites listed here test upload and download speeds, while also providing useful assessments on details like jitter or latency. Your results ...